A flow cytometry analysis of tumour infiltrating T-cells revealed a statistically insignificant trend in the proportion of CD4+ and CD8+ T-cells between the vehicle and IgG control treatment group and all single and double-treated mice (Fig. 6b). This evidence concerns the gene CD8A and neoplasm.